Multiple sclerosis (MS) is an inflammatory disease in which the immune system attacks the central nervous system. The molecular mechanisms underlying this disease remain poorly understood. In ...
Global Central Nervous System Therapeutics Market is valued at approximately USD 143.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period ...
Smoldering-associated worsening (SAW) of multiple sclerosis (MS) deserves a broader, more comprehensive approach to diagnosis, treatment, and research that goes beyond neurologists’ understanding of ...